AKER Akers Biosciences, Inc. Stock Quote

AKER [NASD]

Healthcare | Medical Instruments & Supplies | USA

Index	-	P/E	-	EPS (ttm)	-2.86	Insider Own	16.05%	Shs Outstand	7.63M	Perf Week	8.62%
Market Cap	22.63M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	7.44M	Perf Month	26.63%
Income	-10.40M	PEG	-	EPS next Q	-	Inst Own	16.40%	Short Float	8.82%	Perf Quarter	11.01%
Sales	1.58M	P/S	14.35	EPS this Y	73.30%	Inst Trans	84.39%	Short Ratio	0.49	Perf Half Y	-55.44%
Book/sh	2.76	P/B	0.91	EPS next Y	-	ROA	-114.30%	Target Price	-	Perf Year	-26.96%
Cash/sh	2.57	P/C	0.98	EPS next 5Y	-	ROE	-136.30%	52W Range	1.55 - 8.85	Perf YTD	26.63%
Dividend	-	P/FCF	-	EPS past 5Y	45.10%	ROI	-42.30%	52W High	-71.53%	Beta	0.31
Dividend %	-	Quick Ratio	-	Sales past 5Y	-18.70%	Gross Margin	-	52W Low	62.58%	ATR	0.14
Employees	12	Current Ratio	9.20	Sales Q/Q	-	Oper. Margin	-	RSI (14)	63.60	Volatility	7.27% 6.34%
Optionable	No	Debt/Eq	0.00	EPS Q/Q	74.80%	Profit Margin	-	Rel Volume	0.30	Prev Close	2.65
Shortable	Yes	LT Debt/Eq	0.00	Earnings	-	Payout	-	Avg Volume	1.34M	Price	2.52
Recom	-	SMA20	13.94%	SMA50	23.27%	SMA200	-20.36%	Volume	401,704	Change	-4.91%

Jan-02-21 07:30AM	MERGER INVESTIGATION ALERT: Halper Sadeh LLP Encourages HMSY, HCAP, CBMG, and AKER Shareholders to Contact the Firm ACCESSWIRE
Dec-30-20 08:49PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds HLIX, XLNX, SNSS, and AKER Shareholders About Its Ongoing Investigations PR Newswire
Dec-19-20 04:55PM	SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - AKER, INFO, SNSS, WORK, WDR PR Newswire
Dec-17-20 11:13PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations PR Newswire
Dec-12-20 09:27AM	INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm IPHI, TNAV, NAV, AKER GlobeNewswire
Dec-10-20 08:37PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders About Its Ongoing Investigations PR Newswire
Dec-05-20 08:30AM	ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to Contact the Firm PR Newswire
Dec-03-20 10:32PM	SHAREHOLDER ALERT: WeissLaw LLP Reminds AKER, CBMG, HLIX, and MCAC Shareholders About Its Ongoing Investigations PR Newswire
01:16PM	AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER Business Wire
Dec-02-20 09:00AM	Akers Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent Business Wire
Dec-01-20 07:00PM	Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm NAV, UROV, HDS, AKER GlobeNewswire
11:09AM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers GlobeNewswire
Nov-25-20 10:42PM	Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm UROV, HDS, AKER, GV GlobeNewswire
08:01AM	Lifshitz Law Firm, P.C. Announces Investigation of AKER, EMIS, HDS, IPHI, PNM, TGC, GV and UROV PR Newswire
Nov-20-20 09:55PM	ALERT: Halper Sadeh LLP Continues to Investigate the Following Mergers; Investors are Encouraged to Contact the Firm HDS, AKER, UROV ACCESSWIRE
Nov-19-20 08:19PM	WeissLaw LLP Reminds ALSK, EIGI, AKER, and TNAV Shareholders About Its Ongoing Investigations PR Newswire
06:11PM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of HDS, UROV, AKER, and TGC Mergers GlobeNewswire
Nov-18-20 04:51PM	SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Akers Biosciences, Inc. - AKER PR Newswire
08:00AM	REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals Business Wire
08:00AM	Halper Sadeh LLP Investigates the Following Mergers; Shareholders are Encouraged to Contact the Firm HDS, UROV, AKER, NAV GlobeNewswire
Nov-17-20 08:16PM	AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER Business Wire
03:55PM	RM LAW Announces Investigation of Akers Biosciences, Inc. PR Newswire
12:10PM	Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm PR Newswire
Nov-13-20 11:31AM	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Akers Biosciences, Inc. Merger GlobeNewswire -9.46%
Nov-12-20 09:38PM	SHAREHOLDER ALERT: WeissLaw LLP Investigates Akers Biosciences, Inc. PR Newswire +29.07%
06:57PM	SHAREHOLDER NOTICE: Brodsky & Smith, LLC Announces an Investigation of Akers Biosciences, Inc. (NASDAQ:AKER) ACCESSWIRE
03:21PM	ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Akers Biosciences, Inc. PR Newswire
12:54PM	Akers Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Akers Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm AKER Business Wire
09:00AM	Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement Business Wire
Aug-27-20 09:00AM	Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive Proof of Concept Results GlobeNewswire -31.49%
Aug-11-20 08:00AM	Akers Biosciences Announces $6.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire -16.82%
Jul-07-20 09:00AM	Akers Biosciences and Premas Biotech Announce Initiation of Animal Studies GlobeNewswire
May-29-20 02:22PM	Hedge Funds Are Nibbling On Akers Biosciences Inc (AKER) Insider Monkey
May-18-20 05:33PM	Akers Biosciences Closes $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire
May-14-20 02:01PM	Microcap Akers Biosciences Spikes on Covid-Vaccine Progress TheStreet.com
01:00PM	Akers Biosciences Announces $4.8 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire
09:33AM	Akers Biosciences and Premas Biotech Announce Successful Completion of Vaccine Prototype & Obtained First Images of VLP GlobeNewswire
Apr-24-20 10:19AM	Here's How Akers Biosciences and Premas Biotech Plan To Knock Out COVID-19 Virus; Company Halfway Through Four Milestone Plan Newsfile +7.73%
Apr-09-20 11:01AM	Akers Biosciences plans $4.6M stock sale, advances COVID-19 vaccine candidate American City Business Journals -13.78%
Apr-08-20 11:10AM	Akers Says It's Halfway Through Plan To Develop COVID-19 Vaccine Candidate Benzinga
09:25AM	Akers Biosciences and Premas Biotech Announce Successful Expression of Coronavirus Antigens GlobeNewswire
Apr-07-20 10:53AM	Akers Biosciences Announces $4.6 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules GlobeNewswire +21.54%
Apr-06-20 09:25AM	Akers Biosciences and Premas Biotech Announce Progress in its Vaccine Development for Covid-19 GlobeNewswire +147.49%
Mar-24-20 05:14PM	South Jersey company's stock closes up 22% after coronavirus vaccine deal American City Business Journals +19.70%
04:06PM	Akers Biosciences Schedules Conference Call to Discuss Licensing Announcement with Premas Biotech for a Coronvirus Vaccine Candidate GlobeNewswire
09:00AM	Akers Biosciences Acquires Licenses to Coronavirus Vaccine Candidate from Premas Biotech GlobeNewswire
Jan-17-20 05:00PM	Akers Biosciences, Inc. Provides Notice of Proposed Settlement of Derivative Litigation GlobeNewswire
Dec-11-19 09:30AM	Akers BioSciences Regains Compliance with Nasdaq Listing Standards GlobeNewswire +8.42%
Dec-10-19 11:30AM	Akers Biosciences to Present at the Investor Summit on December 17th in Philadelphia ACCESSWIRE
Dec-09-19 11:40AM	Akers BioSciences, Inc. Announces Closing of Approximately $8 Million Public Offering GlobeNewswire
Dec-06-19 09:30AM	Akers Biosciences to Attend Hemp Industry Daily Forum in Las Vegas, Nevada GlobeNewswire
07:39AM	The Daily Biotech Pulse: Cassava Gains On Alzheimer's Presentation, Bristol-Myers Hikes Dividend Benzinga
Dec-05-19 04:55PM	South Jersey medical device maker raising $8M through stock offering American City Business Journals -43.06%
09:25AM	Akers BioSciences, Inc. Announces Pricing of Approximately $8 Million Public Offering GlobeNewswire
08:45AM	Akers Biosciences Continues Strategic Review; Explores Leveraging its 30-years of Laboratory Operations to Enter into the Hemp and Minor Cannabinoid Processing Industry GlobeNewswire
Nov-22-19 09:15AM	Akers Biosciences, Inc. Announces One-for-Twenty Four Reverse Stock Split GlobeNewswire
Sep-25-19 03:15PM	AKER: Final Settlement Hearing Rescheduled to December 20, 2019 GlobeNewswire
Aug-15-19 09:00AM	Akers Biosciences Reports Q2 2019 Earnings GlobeNewswire -13.46%
Aug-05-19 02:29PM	Local companies impacted by trade war-fueled stock market decline American City Business Journals
Jul-29-19 08:00AM	The Rosen Law Firm, P.A. Announces Proposed Class Action Settlement on Behalf of Purchasers of Akers Biosciences, Inc. Common Stock -- AKER GlobeNewswire
May-20-19 05:38PM	Akers Biosciences Reports Q1 2019 Earnings GlobeNewswire
Apr-02-19 02:15PM	As losses mount, medical device maker continues pursuit of 'strategic alternatives' American City Business Journals
Apr-01-19 05:31PM	Akers Biosciences Reports Fiscal Year 2018 Earnings GlobeNewswire
Feb-22-19 07:20AM	Factors of Influence in 2019, Key Indicators and Opportunity within ARRIS International plc, Edwards Lifesciences, DENTSPLY SIRONA, Vail Resorts, Akers Biosciences, and DURECT New Research Emphasizes Economic Growth GlobeNewswire -6.00%
Dec-31-18 10:50AM	4 Healthcare Stocks That Are Raising Eyebrows ACCESSWIRE -10.69%
Dec-28-18 11:45AM	These 4 Healthcare Stocks Are Heating Up ACCESSWIRE +26.82%
Nov-30-18 08:30AM	Market Trends Toward New Normal in Gartner, CONVERGEONE HLD, Syros Pharmaceuticals, Akers Biosciences, Edge Therapeutics, and Cracker Barrel Old Country Store Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire -8.48%
Nov-20-18 03:09PM	This Tiny Biotech Firm Is Weighing An Entrance Into Cannabis Benzinga -6.29%
06:50AM	Todays Research Reports on Stocks to Watch: Akers Biosciences and Align Technology ACCESSWIRE
Nov-19-18 04:48PM	[$$] Biotech Learns the Magic Word The Wall Street Journal +42.28%
02:34PM	Apple shares down after cutting production orders for all three iphone models Yahoo Finance Video
01:59PM	Failing biotech company mentions pot business, stock soars 70% MarketWatch
10:23AM	South Jersey medical device firm exploring cannabis industry combination American City Business Journals
09:01AM	Akers Biosciences Exploring Potential Business Combinations in Alternative Sectors Including Cannabis Industry GlobeNewswire
Nov-15-18 07:00AM	Akers Biosciences Announces Q3 2018 Earnings GlobeNewswire -29.52%
Nov-07-18 01:16PM	South Jersey medical-device company exploring 'strategic alternatives' American City Business Journals -20.38%
09:15AM	Akers Biosciences Announces Intention to Explore Strategic Alternatives to Maximize Shareholder Value GlobeNewswire
Oct-23-18 07:40AM	Market Trends Toward New Normal in PTC Therapeutics, AeroVironment, Autodesk, Coca-Cola Bottling Co. Consolidated, Akers Biosciences, and TEGNA Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Oct-08-18 12:08PM	South Jersey medical device company makes CEO switch, settles lawsuit American City Business Journals -9.57%
02:00AM	Akers Biosciences Announces a Leadership Change, Strategic Update, Legal Settlement and an AIM Update GlobeNewswire
Aug-21-18 08:20AM	Market Trends Toward New Normal in Addus HomeCare, Sandstorm Gold, BioSpecifics Technologies, Itau Unibanco Holding S.A, Akers Biosciences, and Kosmos Energy Emerging Consolidated Expectations, Analyst Ratings GlobeNewswire
Aug-14-18 04:18PM	Akers Biosciences Announces Q2 and H1 2018 Earnings GlobeNewswire +11.99%
Aug-13-18 12:05PM	DEADLINE TODAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
10:21AM	FINAL DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline: August 13, 2018 ACCESSWIRE
Aug-12-18 09:40PM	DEADLINE MONDAY: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm ACCESSWIRE
11:00AM	AKER AUG 13 DEADLINE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First Filed Case AKER Business Wire
Aug-11-18 09:00AM	ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Akers Biosciences, Inc. AKER ACCESSWIRE
08:00AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline AKER GlobeNewswire
08:00AM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline AKER GlobeNewswire
Aug-10-18 07:42PM	The Law Offices of Howard G. Smith Reminds Investors of August 13th Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER) Business Wire +15.01%
12:50PM	AUGUST 13 DEADLINE: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
Aug-09-18 06:06PM	Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against PG&E, Akers Biosciences, and UNUM and Encourages Investors to Contact the Firm GlobeNewswire +10.93%
05:20PM	August 13th Deadline Alert: Glancy Prongay & Murray LLP Reminds Investors of the Deadline in the Class Action Lawsuit Against Akers Biosciences, Inc. (AKER) Business Wire
02:57PM	IMPORTANT DEADLINE REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
Aug-08-18 07:11PM	Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Akers Biosciences, Inc. Investors Business Wire -14.96%
04:10PM	SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akers Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadline - AKER ACCESSWIRE
03:52PM	MONDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Business Wire
Aug-07-18 12:40PM	FINAL DEADLINE ALERT: The Schall Law Firm Announces it is Investigating Claims Against Akers Biosciences, Inc. and Encourages Investors with Losses in Excess of $250,000 to Contact the Firm ACCESSWIRE
11:00AM	AKER ALERT NOTICE: Rosen Law Firm Reminds Akers Biosciences, Inc. Investors of Important Deadline in First File Case AKER GlobeNewswire
10:00AM	DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akers Biosciences, Inc. (AKER) & Lead Plaintiff Deadline: August 13, 2018 GlobeNewswire

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Hudson Bay Capital Management	10% Owner	Feb 28	Sale	2.81	638	1,793	240,305	Mar 03 02:55 PM
Hudson Bay Capital Management	10% Owner	Feb 27	Sale	2.72	15,300	41,616	240,943	Feb 27 04:06 PM
Hudson Bay Capital Management	10% Owner	Feb 25	Sale	2.92	13,000	37,960	256,243	Feb 27 04:06 PM

open in yahoo | open in reuters | open in google

Upgrade your FINVIZ experience